Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known whether paclitaxel is more effective than
docetaxel for breast cancer.
PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in
treating women with stage IIIB or metastatic breast cancer.